← Back to Funding Now

United Kingdom / Science and engineering / Early stage

Funding Now

Connect Now

Specialist venture capital and company-building for UK science and engineering, from early research to commercial businesses.

HeadquartersHarwell, United Kingdom
StagesPre-seed and seed
GeographyUK-centred
Initial investmentUp to £1.5 million

01 / The firm

Patient capital for UK science

Longwall backs IP-protected ventures in advanced manufacturing, life sciences, medical technologies, defence, clean energy and adjacent fields. It leads at pre-seed or seed, including before a proven market, and supports companies through complex development cycles.

Longwall Venture Partners LLP, registered in England and Wales as OC362933, operates from Harwell. Its registered office is in Thame. Venture activity began in 2008; the LLP was incorporated in 2011.

Its four fund generations include Oxford Technology ECF, Longwall Ventures ECF, Longwall Ventures 3 ECF and Longwall 4.

Longwall currently states an initial investment of up to £1.5 million. The British Business Bank's May 27, 2026 Fund 4 announcement described £500,000-£2 million investments, £86.2 million raised and a £100 million target.

02 / Portfolio

Explore by sector

Selected investments from Longwall's portfolio, followed by historical exits.

BioTech

Tools for biological research, diagnostics and therapy development.

Lightcast Discovery

Lightcast Discovery

Light-controlled microdroplet technology for functional single-cell analysis and screening.

Biofidelity

Biofidelity

Molecular technologies for genomic biomarker testing, including Aspyre and Enspyre.

Kinomica

Kinomica

Phosphoproteomic analysis of cell signalling to support drug development and treatment research.

MFX

MFX

Automated microfluidic bioprocessing for cell and gene therapy development. Prototypes are for research and development, not clinical or therapeutic use.

Oxford Cancer Biomarkers

Oxford Cancer Biomarkers

Proprietary oncology biomarkers and digital-pathology analysis tools for cancer treatment decisions.

OxSonics

OxSonics

SonoTran ultrasound-driven delivery platform for solid-tumour therapies. Investigational use only, not approved for sale.

Energy & Materials

Chemical-process spectroscopy, methane sensing and photovoltaic materials.

Mirico

Mirico

Laser-dispersion spectroscopy for detecting, locating and quantifying methane emissions.

Industrial & Scientific Tech

Metal additive manufacturing, optical sensing and analytical instrumentation.

Focus Sensors

Focus Sensors

Distributed optical sensing hardware for acoustic and movement monitoring over fibre infrastructure.

Verdel Instruments

Verdel Instruments

Quadrupole two-dimensional mass spectrometry for improving analytical separation in QTOF instruments.

AgriTech

Ultrasonic aeroponics technology for controlled-environment agriculture.

Space Tech

Deployable antenna systems for spacecraft.

Oxford Space Systems

Oxford Space Systems

Deployable spacecraft antennas designed around low mass and compact stowage.

Historical DeepTech exits

Diamond Microwave / Historical

Diamond Microwave

Gallium-nitride and gallium-arsenide microwave solid-state power amplifiers. Longwall marks its investment exited; the company describes TMD as a shareholder, not an outright acquirer.

Non-DeepTech portfolio

03 / People

Investment team

Co-founder Michael Penington (1958-2024) retired in 2023. He is remembered on Longwall's team page and is not a current contact.

04 / Connect

Start a conversation

For general enquiries, use Longwall's published firm mailbox. The investment team biographies above describe each person's focus.

Who's raising. Who's funding. What's next in DeepTech.